Inari VISION registry for patients treated with Inari devices
Part of Heart & circulation, Lungs & breathing clinical trials.
This registry collects information on people who have already received treatment with an Inari Medical device, such as a catheter used to remove blood clots. It helps doctors learn more about how well these devices work over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been treated with an eligible Inari Medical device.
- You must be able to give informed consent (understand and agree to participate).
- Your procedure must have happened within a certain time window to join the registry.
- You must not be pregnant or breastfeeding at the time of enrollment.
- You must be available for follow-up visits or calls.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks how patients do long-term after having a clot in the lung treated with a device called the Indigo Aspiration System. It aims to better understand safety and outcomes over time.
This is a registry—a database that tracks patient outcomes—for people receiving Okami Medical devices. By joining, you help doctors understand how well these devices work and whether they're safe over time.
This is a patient registry that collects health information from adults who get Abbott vascular devices during a planned procedure. It helps Abbott and doctors understand how these devices perform in everyday care.
This registry tracks people who get a VIVO ISAR stent to see how well it works and how safe it is. If you have a stent placed and take blood thinners for three months or less, you might be able to join.
This study collects health data from people who had a procedure called AngioVac, which uses a suction tube to remove blood clots or infected heart valve tissue. It is a registry study, so it does not involve a new treatment; instead, it reviews medical records from past procedures to learn more about safety and effectiveness.
This study follows people who receive a specific Medtronic neurovascular device to learn about safety and performance over time. It may help improve how these devices are used and monitored in real-world care.
Hear when a new Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.